You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

GENGRAF Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Gengraf, and what generic alternatives are available?

Gengraf is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in GENGRAF is cyclosporine. There are eighteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Gengraf

A generic version of GENGRAF was approved as cyclosporine by HIKMA on October 29th, 1999.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for GENGRAF?
  • What are the global sales for GENGRAF?
  • What is Average Wholesale Price for GENGRAF?
Drug patent expirations by year for GENGRAF
Drug Prices for GENGRAF

See drug prices for GENGRAF

Recent Clinical Trials for GENGRAF

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fred Hutchinson Cancer CenterPhase 2
National Cord Blood NetworkPhase 2
Fred Hutchinson Cancer Research CenterPhase 1/Phase 2

See all GENGRAF clinical trials

US Patents and Regulatory Information for GENGRAF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie GENGRAF cyclosporine CAPSULE;ORAL 065003-001 May 12, 2000 AB1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie GENGRAF cyclosporine CAPSULE;ORAL 065003-002 May 12, 2000 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie GENGRAF cyclosporine CAPSULE;ORAL 065003-003 May 12, 2000 AB1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.